Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
Vandana Menon(National Institutes of Health), Mark J. Sarnak(Tufts Medical Center), Andrew S. Levey(Tufts Medical Center), Josef Coresh(New York University), Michael G. Shlipak(San Francisco VA Health Care System), Xuelei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), John W. Kusek(National Institute of Diabetes and Digestive and Kidney Diseases), Allan J. Collins(University of Richmond), Tom Greene(University Medical Center Groningen), Lesley Stevens(Tufts Medical Center), Gerald J. Beck(Cleveland Clinic)
Cited by 203
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
|Annals of Internal Medicine|2006|5.8k